Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Although antibiotic resistance represents a public health emergency, the pipeline of new antibiotics is running dry. Repurposing of old drugs for new clinical applications is an attractive strategy for drug development. We used the bacterial pathogen Pseudomonas aeruginosa as a target for the screening of antivirulence activity among marketed drugs. We found that the antimycotic agent flucytosine inhibits the expression of the iron-starvation σ-factor PvdS, thereby repressing the production of major P. aeruginosa virulence factors, namely pyoverdine, PrpL protease, and exotoxin A. Flucytosine administration at clinically meaningful dosing regimens suppressed P. aeruginosa pathogenicity in a mouse model of lung infection. The in vitro and in vivo activity of flucytosine against P. aeruginosa,combined with its desirable pharmacological properties, paves the way for clinical trials on the anti-P. aeruginosa efficacy of flucytosine in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Iron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788 · cited 1×
“In principle, they combat bacterial infections without exerting the strong selective pressure for resistance imposed by conventional antibiotics, with no predictable detrimental effect on the host microbiota (1).”
BackgroundSiderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584
The struggle for iron - a metal at the host-pathogen interface: Iron at the host-pathogen interface
Nairz, M., Schroll, A., Sonnweber, T., & Weiss, G. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01529.x · Cited by 398 · cited 2×
“Pyoverdine synthesis is stimulated by iron deficiency, a nutritional condition characterizing the biological fluids of infected mammals (11), whereas negative control of pyoverdine synthesis is exerted by the global regulator of bacterial iron homeostasis Fur, which represses pvdS transcription under high-iron conditi…”
Background
Cited by
Quorum-Sensing Systems as Targets for Antivirulence Therapy
Defoirdt, T. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.005 · Cited by 476
Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections
Cornelis, P., & Dingemans, J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00075 · Cited by 382
Drug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 360
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection
Minandri, F., Imperi, F., Frangipani, E., Bonchi, C., Visaggio, D., Facchini, M., Pasquali, P., Bragonzi, A., & Visca, P. (2016) · Infection and Immunity · doi:10.1128/iai.00098-16 · Cited by 228
“5 and 6) (31) and multiorgan dissemination of bacterial cells (with P.”
BackgroundMethodSelf-citationChadha, J., Harjai, K., & Chhibber, S. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15784 · Cited by 180
Metadata
- Authors
- Imperi, F., Massai, F., Facchini, M., Frangipani, E., Visaggio, D., Leoni, L., Bragonzi, A., & Visca, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-04-08
- Volume
- 110
- Issue
- 18
- Pages
- 7458-7463
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2068986902
- Cited by
- 153
- References
- 5
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. https://app.cochat.ai/papers/10.1073/pnas.1222706110
- The paper
- Imperi, F., Massai, F., Facchini, M., Frangipani, E., Visaggio, D., Leoni, L., Bragonzi, A., & Visca, P. (2013). Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1222706110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.